Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Article

  • Article

    Inhaled Amikacin in the First 72 Hours of Mechanical Ventilation Reduced the Incidence of VAP

    January 1, 2025

    Clinical question: Does inhaled amikacin reduce the incidence of ventilator-associated pneumonia (VAP) in critically ill patients? Background: VAP is a common and serious complication in patients on...

  • Article

    90-Day Mortality Among Septic Patients Given Piperacillin-Tazobactam Versus Cefepime

    January 1, 2025

    Clinical question: In patients with undifferentiated sepsis without an indication for anaerobic coverage, is there increased mortality with the combined use of vancomycin/piperacillin-tazobactam...

  • Article

    Hydrocortisone Plus Fludrocortisone for CAP-Related Septic Shock

    January 1, 2025

    Clinical question: Does hydrocortisone and fludrocortisone reduce all-cause mortality among patients with septic shock due to community-acquired pneumonia (CAP)? Background: A meta-analysis of 17...

  • Article

    Empagliflozin After Acute Myocardial Infarction (EMPACT-MI)

    January 1, 2025

    Clinical question: Does starting empagliflozin for patients with acute myocardial infarction (AMI) and new onset systolic heart failure (HF) or congestive symptoms reduce the risk of first...

  • Article

    Clinical Risk Score Predicts Arterial Thrombosis in Survivors of Intracranial Hemorrhage

    January 1, 2025

    Clinical question: Among survivors of hemorrhagic stroke, who is at high long-term risk of arterial thrombosis? Background: Patients who survive intracerebral hemorrhage (ICH) are at increased risk...

  • Article

    Implementing and Evaluating a DBN Initiative in a Large Tertiary Care Urban Hospital

    January 1, 2025

    Clinical question: What is the impact of implementing discharge before noon (DBN) initiatives on discharge time and other factors such as length of stay (LOS), 30-day readmission, and ED boarding...

  • Article

    Understanding Potentially Preventable 7-Day Readmission Rates in Medical Oncology Patients

    January 1, 2025

    Clinical question: What are the rates and the underlying risk factors for seven-day, unplanned, potentially preventable re-admission (PPR), among solid tumor patients in a medical oncology...

  • Article

    SHM Hill Day 2024

    January 1, 2025

    Members of SHM met with legislators and staff to discuss important issues affecting hospitalists and their patients during SHM’s annual Hill Day in September On September 26, 2024, SHM’s...

  • Article

    Global Hospital Medicine

    January 1, 2025

    Dr. Ajala worked at the Tibetan School of Medicine in Dharamsala, India, where she shadowed the Dalai Lama’s personal physician How do U.S. hospitalists find their way into international...

  • Article

    Illicit Medetomidine Use with Fentanyl

    January 1, 2025

    Medetomidine is a non-opioid veterinary anesthetic drug and a synthetic alpha-2-adrenoceptor agonist that is not approved for human use. Increasingly, it’s being used with illicitly manufactured...

Previous1 … 6 7 8 9 10 … 88Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences